4C Mortality Score for COVID 19 Calculator

Clinical calculation support · Verify results before clinical use

Clinical assessment

Complete all fields to calculate the 4C Mortality Score (0–21 points).

—Score
Scoring bands: 18–49, 50–59, 60–69, 70–79, and 80 years or older.
Use the comorbidity definitions from the original 4C score publication.
Below 20: 0; 20–29: +1; 30 or more: +2.
Original score: room-air SpO₂ ≥92% scores 0; below 92% scores +2.
GCS 15: 0 points; GCS below 15: +2 points.
Below 7: 0; 7 to 14 inclusive: +1; above 14: +3.
Below 50: 0; 50–99: +1; 100 or more: +2.

About the 4C Mortality Score

The 4C Mortality Score was developed to stratify the risk of in-hospital death among adults admitted to hospital with COVID-19. It combines eight variables available at initial hospital assessment. The original study reported a score range of 0–21 and validated the score in a large UK hospital cohort.

Scoring criteria

VariableCriterionPoints
Age (years)18–49 / 50–59 / 60–69 / 70–79 / ≥800 / 2 / 4 / 6 / 7
Sex at birthFemale / Male0 / 1
Comorbidities0 / 1 / ≥20 / 1 / 2
Respiratory rate<20 / 20–29 / ≥30 breaths/min0 / 1 / 2
Room-air SpO₂≥92% / <92%0 / 2
GCS15 / <150 / 2
Urea (mmol/L)<7 / 7–14 / >140 / 1 / 3
CRP (mg/L)<50 / 50–99 / ≥1000 / 1 / 2

Risk groups in the original validation cohort

Total scoreRisk groupObserved in-hospital mortality
0–3Low1.2%
4–8Intermediate9.9%
9–14High31.4%
≥15Very high61.5%

References

Knight SR, Ho A, Pius R, et al. Risk stratification of patients admitted to hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020;370:m3339. doi:10.1136/bmj.m3339.
BMJ correction to the original publication. Correction clarifying the first urea cut-off as <7 mmol/L and CRP units as mg/L. BMJ. 2020;371:m4334. doi:10.1136/bmj.m4334.
ISARIC 4C Consortium. 4C Mortality Score resources and validation information. Official score information.
Clinical disclaimer: This calculator is intended for clinical risk stratification in adults admitted to hospital with COVID-19. It does not diagnose COVID-19, determine treatment by itself, or replace clinician judgement. The score was developed during earlier phases of the pandemic; calibration and absolute mortality rates may differ across populations, variants, vaccination status, treatments, and healthcare settings. Use room-air oxygen saturation for the original scoring rule and interpret results in the patient's clinical context.